FDA Recalls Hydromorphone and Bupivacaine Due to Fungal Contamination
Coast Quality Pharmacy is recalling Hydromorphone HCL and Bupivacaine HCL products due to the detection of Talaromyces rotundus fungi during environmental sampling.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The source text does not report any illnesses, injuries, or fatalities, and the hazard is identified through environmental sampling rather than confirmed patient harm, fitting the criteria for a moderate severity score.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a recall for Hydromorphone HCL and Bupivacaine HCL in all strengths, doses, and packaging. The recall is being conducted by Coast Quality Pharmacy, LLC dba Anazao Health, located in Tampa, Florida.
The recall was initiated because environmental sampling revealed the presence of Talaromyces rotundus, a type of fungi. This finding indicates a lack of processing controls in the manufacturing or handling environment. The affected products include all lots filled on August 26, 2019, and dispensed between August 26 and August 29, 2019, that remain within their expiration dates.
These products were distributed nationwide in the United States. Consumers and healthcare providers should stop using these specific products and contact their pharmacist or the recalling firm for further instructions on disposal or replacement.
The recalled product
- Product
- Hydromorphone HCL and Bupivacaine HCL in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.
- Manufacturer
- Coast Quality Pharmacy, LLC dba Anazao Health
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots filled 08/26/2019 and dispensed 08/26-29/2019 remaining within expiry.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 31 recalled by Coast Quality Pharmacy, LLC dba Anazao Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 31 products in this recall →Related recalls
Same manufacturer · Coast Quality Pharmacy, LLC dba Anazao Health
See all →- HighProgesterone 200 mg compounded tablets recalled for embedded metal fragments
FDA (Drugs) · 2024-07-03
- ModerateAnazao Health Recalls Clonidine and Hydromorphone Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Hydromorphone, Baclofen, and Clonidine Combination Drugs
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Compounded Sufentanil Syringes Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
- SevereAnazao Health Recalls Baclofen, Clonidine, and Morphine Sulfate Due to Fungal Contamination
FDA (Drugs) · 2019-12-18
Same hazard · fungal contamination
See all →- SevereChloraPrep One-Step Topical Antiseptic Recalled for Non-Sterility
FDA (Drugs) · 2026-07-01
- SevereChloraPrep One-Step Antiseptic Solution Recall Due to Sterility Concerns
FDA (Drugs) · 2026-07-01
- HighCell wash solution recalled over fungal contamination of an affected lot
FDA (Devices) · 2026-01-21
- SevereOrajel Baby teething swabs recalled over fungal contamination of swabs
FDA (Drugs) · 2025-07-09
- SevereZicam cold remedy nasal swabs recalled over fungal contamination
FDA (Drugs) · 2025-07-09